---
figid: PMC3201097__bcbcr-5-2011-209f1
figlink: /pmc/articles/PMC3201097/figure/f1-bcbcr-5-2011-209/
number: F1
caption: 'The hormone signaling pathway and its inhibition as therapy in breast cancer.
  A) Estrogen receptor signaling. B) Receptor signaling inhibited by the selective
  estrogen receptor modulator tamoxifen and C) by aromatase inhibition.Abbreviations:
  A, androstenedione; AF, activating function; AND-5, androstenediol-5; AND-5S, androstenediol-5
  sulfate; DHEA, dehydroepiandrosterone; DHEA-S, dehydroepiandrosterone sulfate; E,
  estrogen; E1, estrone; E2, estradiol; ER, estrogen receptor; ERE, estrogen response
  element; RNA Pol II, ribonucleic acid polymerase II; T, tamoxifen. Panels A and
  B reprinted with permission from Johnston SR 2005. Panel C adapted with permission
  from Labrie F, Luu-The V, Lin SX, et al. J Mol Endocrinol 25:1–16 © Society for
  Endocrinology (2000).'
pmcid: PMC3201097
papertitle: Exemestane in the Adjuvant Treatment of Breast Cancer in Postmenopausal
  Women.
reftext: Muaiad Kittaneh, et al. Breast Cancer (Auckl). 2011;5:209-226.
pmc_ranked_result_index: '10636'
pathway_score: 0.8975703
filename: bcbcr-5-2011-209f1.jpg
figtitle: The hormone signaling pathway and its inhibition as therapy in breast cancer
year: '2011'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3201097__bcbcr-5-2011-209f1.html
  '@type': Dataset
  description: 'The hormone signaling pathway and its inhibition as therapy in breast
    cancer. A) Estrogen receptor signaling. B) Receptor signaling inhibited by the
    selective estrogen receptor modulator tamoxifen and C) by aromatase inhibition.Abbreviations:
    A, androstenedione; AF, activating function; AND-5, androstenediol-5; AND-5S,
    androstenediol-5 sulfate; DHEA, dehydroepiandrosterone; DHEA-S, dehydroepiandrosterone
    sulfate; E, estrogen; E1, estrone; E2, estradiol; ER, estrogen receptor; ERE,
    estrogen response element; RNA Pol II, ribonucleic acid polymerase II; T, tamoxifen.
    Panels A and B reprinted with permission from Johnston SR 2005. Panel C adapted
    with permission from Labrie F, Luu-The V, Lin SX, et al. J Mol Endocrinol 25:1–16
    © Society for Endocrinology (2000).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ELF3
  - CYP19A1
  - EFNA5
  - Androstenedione
  - DHEA
  - estrogen
  - Testosterone
genes:
- word: ER+T
  symbol: ERT
  source: hgnc_alias_symbol
  hgnc_symbol: ELF3
  entrez: '1999'
- word: CYP19
  symbol: CYP19
  source: hgnc_prev_symbol
  hgnc_symbol: CYP19A1
  entrez: '1588'
- word: Aromatase
  symbol: aromatase
  source: hgnc_alias_symbol
  hgnc_symbol: CYP19A1
  entrez: '1588'
- word: AF1
  symbol: AF1
  source: hgnc_alias_symbol
  hgnc_symbol: EFNA5
  entrez: '1946'
- word: aromatase
  symbol: aromatase
  source: hgnc_alias_symbol
  hgnc_symbol: CYP19A1
  entrez: '1588'
chemicals:
- word: Androstenedione
  source: MESH
  identifier: D000735
- word: DHEA
  source: MESH
  identifier: D003687
- word: estrogen
  source: MESH
  identifier: D004967
- word: Testosterone
  source: MESH
  identifier: D013739
diseases: []
figid_alias: PMC3201097__F1
redirect_from: /figures/PMC3201097__F1
figtype: Figure
---
